| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 143 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 143 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 143 |
| 3 | ETOPOSIDE | 118 |
| 4 | IFOSFAMIDE | 92 |
| 5 | IFOSFAMIDE FOR INJECTION | 92 |
| 6 | DOXORUBICIN | 82 |
| 7 | BUSULFAN | 63 |
| 8 | DACTINOMYCIN | 55 |
| 9 | METHOTREXATE SODIUM | 38 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUINIDINE SULFATE TABLET | 13 | 0.0909 |
| 1 | PROCAINAMIDE HYDROCHLORIDE | 17 | 0.0688 |
| 2 | ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC | 1 | 0.0345 |
| 3 | DACTINOMYCIN | 55 | 0.0249 |
| 4 | CHLORPROMAZINE HYDROCHLORIDE | 11 | 0.0115 |
| 5 | NIROGACESTAT | 5 | 0.0054 |
| 6 | PENTOSTATIN | 5 | 0.0048 |
| 7 | IFOSFAMIDE FOR INJECTION | 92 | 0.0043 |
| 8 | BUSULFAN | 63 | 0.0040 |
| 9 | HYDRALAZINE HYDROCHLORIDE | 10 | 0.0037 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 246 |
| 1 | Topoisomerase Inhibitor [EPC] | 117 |
| 2 | Actinomycin [EPC] | 55 |
| 3 | Corticosteroid [EPC] | 53 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 37 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 36 |
| 6 | Platinum-based Drug [EPC] | 33 |
| 7 | Microtubule Inhibitor [EPC] | 32 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 28 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 55 | 0.0249 |
| 1 | Gamma Secretase Inhibitor [EPC] | 5 | 0.0054 |
| 2 | CD22-directed Immunoconjugate [EPC] | 5 | 0.0017 |
| 3 | Topoisomerase Inhibitor [EPC] | 117 | 0.0015 |
| 4 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 5 | Gonadotropin [EPC] | 3 | 0.0014 |
| 6 | Alkylating Drug [EPC] | 246 | 0.0010 |
| 7 | Allylamine Antifungal [EPC] | 6 | 0.0008 |
| 8 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 9 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |